Glucosamine

Producers shown on SFDA

(Record date:17/09/2021）

Producer:Guangdong Yishu Pharmaceutical Co., Ltd. was established in 2000. The company is located in the old plant in Dinghu District, Zhaoqing City, covering an area of 30000 square meters. It has built a solid preparation workshop of 2000 square meters, a chemical synthetic API workshop of 1800 square meters, an office laboratory building of 1600 square meters and a warehouse of 1300 square meters.

Staff size:200-299 persons

Registered capital:RMB 87.7108 million

Producer:Shanxi Tongda Pharmaceutical Co., Ltd. is a foreign-funded enterprise, formerly known as Shanxi Sanjiu Tongda Pharmaceutical Co., Ltd. the company covers an area of 60000 square meters and a construction area of 38000 square meters. It mainly produces five categories of products such as penicillin, cephalosporin, oral solid preparations, suppositories and API.

Staff size:200-299 persons

Registered capital:RMB 50 million

Producer:Shanxi Kangbao Biological Product Co., Ltd., founded in 1991, is a national key high-tech enterprise mainly engaged in the R & D and production of blood products, and passed the GMP certification of blood products enterprises in 1998. The company has strong development strength, leading technical level, first-class production and testing equipment Scientific and standardized operation and management and perfect quality assurance system.

The company has blood products, biopharmaceuticals, genetic engineering vaccines, chemical drugs and other varieties. While vigorously developing blood products, the company has also developed and produced API, small volume injection, lyophilized powder injection, tablet and oral liquid. All these workshops have passed GMP certification.

Staff size:700-799 persons

Registered capital:RMB 69.2 million

Producer:Zhejiang Hailisheng Pharmaceutical Co., Ltd., founded in 1989, is now a holding subsidiary of Qianyuan pharmaceutical. The company covers an area of about   26637 square meters, with a construction area of 24223 square meters.

The company's main production workshop has passed the national GMP certification. The main products are: raw materials and preparations of natural marine drugs, natural mineral drugs, chemical synthetic drugs, intermediate raw materials, marine health food, series of marine cosmetics, etc.

Staff size:200-299 persons

Registered capital:RMB 20 million

Producer:Zhejiang Chengyi Pharmaceutical Co.,Ltd. was founded in 1966 and is now a comprehensive modern pharmaceutical enterprise specializing in the production of capsules, injections, tablets, APIs and pharmaceutical intermediates. It landed on the main board of Shanghai Stock Exchange on March 15, 2017.

The company can produce more than 60 varieties and nearly 100 specifications of drugs. All products have passed the national GMP certification, and many products have passed the certification of FDA, EMEA, TGA, MHRA, cofepris and other countries and regions.

Staff size:About 700 persons

Registered capital:RMB 233 million 800 thousand

Producer:Zhejiang Hisun Pharmaceutical Co., Ltd. was founded in 1956. In 2000, Hisun issued A-shares in Shanghai stock exchange, but it continues to remain a state-owned enterprise. Hisun is one of the largest antibiotics and anti-tumor drug production bases in the country. It has won several titles, including first batch of innovative enterprises, national technology innovation demonstration enterprises, and "National Industrial Brand Demonstration Enterprise” of the Chinese Ministry of Industry and Information Technology. 

Hisun began as a small chemical factory and entered the pharmaceutical field in the early 1970s. Since its founding over 60 years ago in 1956, Hisun has amassed a total asset worth of 21.8 billion RMB. While Hisun is primarily engaged in the R&D, manufacturing, and sales and marking of API and final dosage forms of chemical and biological drugs, its core business has extended to include branded generic drugs, biosimilarst and other innovative drugs. 

Staff size:About 9000 persns

Registered capital:RMB 1 billion 169 million

For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978